Fig. 1 · Structure
Documents & Downloads
GSK 124576A
bc1 Complex Inhibitor
GSK 124576A is a selective inhibitor of the cytochrome bc1 complex in Mycobacterium tuberculosis. This compound, classified as a 2-(quinolin-4-yloxy)acetamide, exhibits potent activity against this pathogen, making it a valuable tool for tuberculosis research. GSK 124576A can be employed to investigate the biochemical pathways involved in mycobacterial respiration and to develop potential therapeutic strategies targeting tuberculosis infections.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 1443139-14-7 |
| Applications | bc1 Complex Inhibitor |
| Formula | C19H17BrN2O2 |
| Molecular Weight | 385.26 |
| SMILES | O=C(NCC=1C=CC=CC1)COC2=CC(=NC=3C=CC(Br)=CC32)C |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.